Embecta Sinks As Outlook Comes In Below Consensus
(RTTNews) - Shares of diabetes care company Embecta Corp. (EMBC) are falling more than 12 percent Friday morning after the company provided full-year profit outlook below the Street view.
Embecta now expects adjusted profit in the range of $1.95 - $2.15 for the full year. Analysts on average, polled by Thomson-Reuters expects the company to report earnings of $2.22 per share.
Revenue for the full year is expected in the range of $1.094 billion - $1.116 billion. This compares with the consensus estimate of $1.1 billion for the year.
EMBC is at $15.48 currently. It has traded in the range of $12.72 - $33.88 in the last 1 year.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.